Nitric oxide-dependent bone marrow progenitor mobilization by carbon monoxide enhances endothelial repair after vascular injury.
Nitric oxide-dependent bone marrow progenitor mobilization by carbon monoxide enhances endothelial repair after vascular injury.
复制标题
DOI:
10.1161/circulationaha.109.887695
复制
发表时间:
2010-02-02
期刊:
影响因子:
37.8
通讯作者:
Otterbein LE
中科院分区:
文献类型:
--
作者:
Wegiel B;Gallo DJ;Raman KG;Karlsson JM;Ozanich B;Chin BY;Tzeng E;Ahmad S;Ahmed A;Baty CJ;Otterbein LE
Carbon monoxide (CO) has emerged as a vascular homeostatic molecule that prevents balloon-angioplasty-induced stenosis via anti-proliferative effects on vascular smooth muscle cells (VSMC). The effects of CO on re-endothelialization have not been evaluated. Exposure to CO has diametrically opposite effects on EC and VSMC proliferation in rodent models of carotid injury. In contrast to blocking VSMC growth, CO administered as a gas or as a CO releasing molecule (CORM) enhances proliferation and motility of EC in vitro greater then 50% vs air controls, and in vivo accelerates re-endothelialization of the denuded artery by day 4 after injury versus day 6 in air-treated animals. CO enhanced EC proliferation via rapid activation of RhoA followed by downstream phosphorylation of Akt, eNOS phosphorylation and a 60% increase in NO generation by the EC. CO drives cell cycle progression through phosphorylation of retinoblastoma (Rb), which is in part dependent on eNOS-generated nitric oxide (NO). Similarly, endothelial repair in vivo requires NO-dependent mobilization of bone marrow-derived EC progenitors (EPC) where CO showed a 4-fold increase in the number of mobilized GFP-Tie-2 positive EPC versus control with a corresponding accelerated deposition of differentiated GFP-Tie-2 positive EC at the site of injury. CO was ineffective in augmenting EC repair and the ensuing development of intimal hyperplasia in enos−/− mice. Collectively our data demonstrate that CO accelerates EC proliferation and vessel repair dependent on NO generation and enhanced recruitment of bone marrow-derived endothelial progenitor cells.